2331 related articles for article (PubMed ID: 21310164)
1. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
2. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).
Rammes G; Seeser F; Mattusch K; Zhu K; Haas L; Kummer M; Heneka M; Herms J; Parsons CG
Neuropharmacology; 2018 Sep; 140():184-192. PubMed ID: 30016667
[TBL] [Abstract][Full Text] [Related]
3. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.
Wang Q; Walsh DM; Rowan MJ; Selkoe DJ; Anwyl R
J Neurosci; 2004 Mar; 24(13):3370-8. PubMed ID: 15056716
[TBL] [Abstract][Full Text] [Related]
4. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
5. Evidence for involvement of group II/III metabotropic glutamate receptors in NMDA receptor-independent long-term potentiation in area CA1 of rat hippocampus.
Grover LM; Yan C
J Neurophysiol; 1999 Dec; 82(6):2956-69. PubMed ID: 10601432
[TBL] [Abstract][Full Text] [Related]
6. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
[TBL] [Abstract][Full Text] [Related]
7. The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region.
Francesconi W; Cammalleri M; Sanna PP
Brain Res; 2004 Oct; 1022(1-2):12-8. PubMed ID: 15353208
[TBL] [Abstract][Full Text] [Related]
8. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
9. Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors.
Li S; Jin M; Koeglsperger T; Shepardson NE; Shankar GM; Selkoe DJ
J Neurosci; 2011 May; 31(18):6627-38. PubMed ID: 21543591
[TBL] [Abstract][Full Text] [Related]
10. Orexin A induces bidirectional modulation of synaptic plasticity: Inhibiting long-term potentiation and preventing depotentiation.
Lu GL; Lee CH; Chiou LC
Neuropharmacology; 2016 Aug; 107():168-180. PubMed ID: 26965217
[TBL] [Abstract][Full Text] [Related]
11. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
Mallon AP; Auberson YP; Stone TW
Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
[TBL] [Abstract][Full Text] [Related]
12. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
Le Vasseur M; Ran I; Lacaille JC
Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
[TBL] [Abstract][Full Text] [Related]
15. The Aβ aggregation modulator MRZ-99030 prevents and even reverses synaptotoxic effects of Aβ
Rammes G; Parsons CG
Neuropharmacology; 2020 Nov; 179():108267. PubMed ID: 32758564
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.
Raymond CR; Ireland DR; Abraham WC
Brain Res; 2003 Apr; 968(2):263-72. PubMed ID: 12663096
[TBL] [Abstract][Full Text] [Related]
17. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
Mol Neurobiol; 2017 Jan; 54(1):748-754. PubMed ID: 26768593
[TBL] [Abstract][Full Text] [Related]
18. The anaesthetic xenon partially restores an amyloid beta-induced impairment in murine hippocampal synaptic plasticity.
Bürge M; Kratzer S; Mattusch C; Hofmann C; Kreuzer M; Parsons CG; Rammes G
Neuropharmacology; 2019 Jun; 151():21-32. PubMed ID: 30940537
[TBL] [Abstract][Full Text] [Related]
19. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
[TBL] [Abstract][Full Text] [Related]
20. Xenon attenuates hippocampal long-term potentiation by diminishing synaptic and extrasynaptic N-methyl-D-aspartate receptor currents.
Kratzer S; Mattusch C; Kochs E; Eder M; Haseneder R; Rammes G
Anesthesiology; 2012 Mar; 116(3):673-82. PubMed ID: 22293720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
